Pharmaceutical Enalapril Maleate Tablet Anti-Hypertensive Enalapril Maleate Powder Purity Enalapril

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Enalapril
• Product Name: Enalapril
• Name: Enalapril Powder
• Appearance: White or off-White Crystalline Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anti-Hypertensive
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 75847-73-3
• Mf: C24h32n2o9
• MW: 376.453
• Density: 1.204
• Melting Point: 143-144.5 Deg C
• Boiling Point: 582.4 C at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 1 Ton/Month

Product Description

Pharmaceutical Enalapril Maleate Tablet Anti-Hypertensive Enalapril Maleate Powder Purity Enalapril

 

Product Description

Product Details

Product Name	Enalapril
CAS No.	75847-73-3
MF	C24H32N2O9
MW	376.453
Appearance and shape	White or off-white crystalline powder

Enalapril is a third-generation angiotensin-converting enzyme inhibitor (ACEI), which plays an important role in safe and effective anti-hypertension, reversal of ventricular hypertrophy, ventricular remodeling and other cardiovascular diseases. As an ACEI drug, it is hydrolyzed into enalapril in vivo after oral administration, which has a strong inhibitory effect on angiotensin-converting enzyme, thereby inhibiting myocardial fiber and cell proliferation, inhibiting myocardial cell apoptosis, and inhibiting myocardial cell apoptosis. Influx of calcium ions, inhibiting heart rate remodeling, thereby controlling heart failure, and at the same time inhibiting the activity of the renin-angiotensin system (RAS) in myocardial tissue, reducing the formation of vasoactive angiotensin II, and improving left ventricular relaxation function, so as to reduce blood pressure and treat high blood pressure.

Application & Function

Enalapril maleate is used for All stages of essential hypertension; renal vascular hypertension; heart failure at all levels, for patients with symptomatic heart failure, this product is also suitable for improving survival, delaying the progression of symptomatic heart failure, reducing the cause of heart failure Hospitalization; prevention of symptomatic heart failure, prevention of coronary artery ischemic events in patients with asymptomatic left ventricular dysfunction, prevention of eft ventricular dysfunction, this product is suitable for reducing the incidence of myocardial infarction.

Specification